MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT. |  |
|
|
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Castagna Michael | Chief Executive Officer | Dec 16 '25 | Option Exercise | 4.55 | 21,310 | 96,960 | 2,526,102 | Dec 16 08:15 PM | | Castagna Michael | Chief Executive Officer | Dec 12 '25 | Option Exercise | 4.55 | 20,806 | 94,667 | 2,525,598 | Dec 16 08:15 PM | | Castagna Michael | Chief Executive Officer | Dec 16 '25 | Sale | 6.00 | 21,310 | 127,860 | 2,504,792 | Dec 16 08:15 PM | | Castagna Michael | Chief Executive Officer | Dec 12 '25 | Sale | 6.00 | 20,806 | 124,836 | 2,504,792 | Dec 16 08:15 PM | | MICHAEL CASTAGNA | Director | Dec 12 '25 | Proposed Sale | 5.81 | 107,920 | 627,015 | | Dec 12 04:26 PM | | Castagna Michael | Chief Executive Officer | Dec 02 '25 | Option Exercise | 4.55 | 107,920 | 491,036 | 2,612,712 | Dec 04 07:32 PM | | Castagna Michael | Chief Executive Officer | Dec 02 '25 | Sale | 5.57 | 107,920 | 601,114 | 2,504,792 | Dec 04 07:32 PM | | Thomson David | EVP Genl Counsel & Secretary | Dec 02 '25 | Option Exercise | 4.58 | 147,780 | 676,788 | 989,499 | Dec 04 07:27 PM | | Thomson David | EVP Genl Counsel & Secretary | Dec 02 '25 | Sale | 5.57 | 147,780 | 823,135 | 841,719 | Dec 04 07:27 PM | | DAVID THOMSON | Officer | Dec 02 '25 | Proposed Sale | 5.43 | 147,780 | 802,445 | | Dec 02 04:24 PM | | MICHAEL CASTAGNA | Director | Dec 02 '25 | Proposed Sale | 5.43 | 107,920 | 586,006 | | Dec 02 04:23 PM | | Singh Sanjay R | EVP Technical Operations | Nov 14 '25 | Sale | 5.03 | 18,777 | 94,448 | 455,211 | Nov 14 08:00 PM | | SANJAY SINGH | Officer | Nov 14 '25 | Proposed Sale | 5.03 | 18,777 | 94,493 | | Nov 14 04:02 PM | | Tross Stuart A | Chief People & Workpl Officer | Sep 16 '25 | Sale | 5.34 | 47,000 | 250,980 | 1,032,013 | Sep 17 07:39 PM | | STUART A TROSS | Officer | Sep 16 '25 | Proposed Sale | 5.34 | 47,000 | 250,792 | | Sep 16 04:05 PM | | Binder Steven B. | Director | Jul 16 '25 | Sale | 3.94 | 75,367 | 296,946 | 830,508 | Jul 17 08:51 PM | | Thomson David | EVP Genl Counsel & Secretary | Jul 16 '25 | Sale | 3.94 | 7,466 | 29,416 | 841,719 | Jul 17 08:46 PM | | DAVID THOMSON | Officer | Jul 16 '25 | Proposed Sale | 3.94 | 7,466 | 29,427 | | Jul 16 04:10 PM | | STEVEN B BINDER | Director | Jul 16 '25 | Proposed Sale | 3.94 | 75,367 | 296,645 | | Jul 16 04:04 PM | | Binder Steven B. | Director | Jun 10 '25 | Sale | 4.00 | 64,085 | 256,340 | 925,258 | Jun 10 08:07 PM | | STEVEN B BINDER | Director | Jun 10 '25 | Proposed Sale | 4.00 | 64,085 | 256,430 | | Jun 10 04:02 PM | | Binder Steven B. | Director | May 20 '25 | Sale | 4.40 | 12,078 | 53,143 | 989,343 | May 20 09:45 PM | | Thomson David | EVP Genl Counsel & Secretary | May 20 '25 | Sale | 4.41 | 2,345 | 10,341 | 879,546 | May 20 09:44 PM | | DAVID THOMSON | Officer | May 20 '25 | Proposed Sale | 4.41 | 2,345 | 10,334 | | May 20 04:14 PM | | STEVEN B BINDER | Director | May 20 '25 | Proposed Sale | 4.40 | 12,078 | 53,184 | | May 20 04:03 PM | | Thomson David | EVP Genl Counsel & Secretary | May 13 '25 | Sale | 4.68 | 32,179 | 150,598 | 772,427 | May 15 09:37 PM | | Binder Steven B. | Director | May 13 '25 | Sale | 4.69 | 80,144 | 375,875 | 1,006,611 | May 15 09:35 PM | | STEVEN B BINDER | Director | May 13 '25 | Proposed Sale | 4.69 | 80,144 | 375,499 | | May 13 04:03 PM | | DAVID THOMSON | Officer | May 13 '25 | Proposed Sale | 4.68 | 32,179 | 150,717 | | May 13 04:02 PM |
|
